MCRB
Seres Therapeutics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
seres therapeutics is a clinical stage biotherapeutic company focused on discovering and developing ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. founded by flagship venturelabs, seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. current candidates span infectious, metabolic, and inflammatory diseases. for more information, please visit http://serestherapeutics.com/.
Market Cap: 147 Million
Primary Exchange: NASDAQ
Website: http://serestherapeutics.com/
Shares Outstanding: 146 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.8465120199208126
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 2549 trading days
From: 2015-06-26 To: 2024-03-07
Lowest Point:
LULU, RH and TLRD among after hour movers
via: SeekingAlpha at 2019-06-12 13:33:29:000
Gainers: RH +22.4% . FRME +8.1% . OXM +3.9% . LULU +3.6% . CIH +3.1% . More news on: RH, First Merchants Corporation, Oxford Industries, Inc., Stocks on the move, , News on ETFs Read more … read more...
LULU, RH and TLRD among after hour movers
via: SeekingAlpha at 2019-06-12 13:33:29:000
Gainers: RH +22.4% . FRME +8.1% . OXM +3.9% . LULU +3.6% . CIH +3.1% . More news on: RH, First Merchants Corporation, Oxford Industries, Inc., Stocks on the move, , News on ETFs Read more … read more...
Seres Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
via: Business Wire at 2019-06-12 12:07:00:000
Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres), a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome, today announced that it is commencing an un… read more...
Seres Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
via: Business Wire at 2019-06-12 12:07:00:000
Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres), a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome, today announced that it is commencing an un… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|